PERFORMANCE OF THE RESTRICTED MEAN SURVIVAL TME IN ANALYZING OVERALL SURVIVAL IN TRIALS STUDYING PERI-OPERATIVE OR NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH ESOPHAGEAL OR JUNCTIONAL CANCER
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.